N eurologic benefits of estrogen replacement therapy in humans include reversal of estrogen deficiency-induced memory dysfunction and reduced risk of Alzheimer's disease (1, 2). Data derived from in vitro analyses indicate that 17␤-estradiol (E 2 ) enhances neuronal survival after oxidative stress, excitotoxic insults, and ␤-amyloid exposure (1-5). Much of the cellular damage caused by these insults can be attributed to dysregulation of calcium (Ca 2ϩ ) homeostasis (6). Ca 2ϩ -induced neurotoxicity is complex and is exemplified by glutamate-induced neurotoxicity, which correlates with the Ca 2ϩ load measured by 45 Ca 2ϩ uptake but not with free intracellular Ca 2ϩ ([Ca 2ϩ ] i ) measured by the fluorescent Ca 2ϩ indicator Fura2 (7). These data suggest a role of subcellular Ca 2ϩ sequestration in glutamate neurotoxicity. An organelle critical for Ca 2ϩ buffering in neurons is mitochondria, which can rapidly accumulate Ca 2ϩ (8). Mitochondrial Ca 2ϩ uptake occurs above a threshold of cytosolic Ca 2ϩ , and is only slowly released, leading to a net accumulation of mitochondrial Ca 2ϩ ([Ca 2ϩ ] m ) and an alteration of physiological [Ca 2ϩ ] i transients (9, 10). The large capacity of mitochondria for Ca 2ϩ could provide a neuroprotective mechanism by reducing cytoplasmic free Ca 2ϩ (10). However, excessive [Ca 2ϩ ] m can lead to detrimental effects, including enhanced free radical production, mitochondrial membrane depolarization, and cell death (11, 12) .
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eurologic benefits of estrogen replacement therapy in humans include reversal of estrogen deficiency-induced memory dysfunction and reduced risk of Alzheimer's disease (1, 2) . Data derived from in vitro analyses indicate that 17␤-estradiol (E 2 ) enhances neuronal survival after oxidative stress, excitotoxic insults, and ␤-amyloid exposure (1) (2) (3) (4) (5) . Much of the cellular damage caused by these insults can be attributed to dysregulation of calcium (Ca 2ϩ ) homeostasis (6) . Ca 2ϩ -induced neurotoxicity is complex and is exemplified by glutamate-induced neurotoxicity, which correlates with the Ca 2ϩ load measured by 45 Ca 2ϩ uptake but not with free intracellular Ca 2ϩ ([Ca 2ϩ ] i ) measured by the fluorescent Ca 2ϩ indicator Fura2 (7) . These data suggest a role of subcellular Ca 2ϩ sequestration in glutamate neurotoxicity. An organelle critical for Ca 2ϩ buffering in neurons is mitochondria, which can rapidly accumulate Ca 2ϩ (8) . Mitochondrial Ca 2ϩ uptake occurs above a threshold of cytosolic Ca 2ϩ , and is only slowly released, leading to a net accumulation of mitochondrial Ca 2ϩ ([Ca 2ϩ ] m ) and an alteration of physiological [Ca 2ϩ ] i transients (9, 10) . The large capacity of mitochondria for Ca 2ϩ could provide a neuroprotective mechanism by reducing cytoplasmic free Ca 2ϩ (10) . However, excessive [Ca 2ϩ ] m can lead to detrimental effects, including enhanced free radical production, mitochondrial membrane depolarization, and cell death (11, 12) .
Hippocampal neurons pretreated with estrogens and then exposed to excitotoxic glutamate respond with an attenuated rise in [Ca 2ϩ ] i and increased survival relative to untreated neurons (1, 13, 14) . We sought to determine the mechanism by which estrogen can promote intracellular Ca 2ϩ homeostasis and survival in the presence of toxic insults that lead to neuronal death via dysregulation of Ca 2ϩ homeostasis. Because of the Ca 2ϩ buffering capacity of mitochondria, we investigated the role of mitochondria in E 2 -induced regulation of [Ca 2ϩ ] i . Because Bcl-2 plays a key role in mitochondrial Ca 2ϩ regulation (15, 16) , the effect of E 2 on Bcl-2 expression was also investigated. Results of these analyses support the hypothesis that E 2 -induced neuroprotection is mediated by attenuation of glutamate-induced [Ca 2ϩ ] i rise via increased mitochondrial sequestration of Ca 2ϩ coupled with increased Bcl-2 expression to promote mitochondrial tolerance of an increased [Ca 2ϩ ] m load.
Materials and Methods
Chemicals. Culture materials were from GIBCO͞BRL. Chemicals were from Sigma unless otherwise noted. E 2 was dissolved in ethanol and diluted in culture medium with final ethanol concentration Ͻ0.001%. Fura2-AM and Fura4F-AM were from Molecular Probes. 45 Ca 2ϩ was from NEN.
Neuronal Culture. Primary hippocampal neurons from embryonic day 18 (E18) rat fetuses were cultured as described and generated cultures 98% neuronal in phenotype (13) . Briefly, hippocampi were dissected from brains of embryonic rats and dissociated by repeated passage through a series of fire-polished constricted Pasteur pipettes. Cells were plated on poly-D-lysinecoated coverslips (22-mm round or 4-mm 2 square gridded) or polyethylenimine-coated six-well plates. Neurons were grown in Neurobasal medium supplemented with 5 units͞ml penicillin, 5 mg͞ml streptomycin, and B27 supplement. Cultures were maintained at 37°C in humidified 5% CO 2 atmosphere for 10-12 days before experimentation.
Measurement of Cytoplasmic Ca 2؉ by Using Fura2-AM and Fura4F-AM.
Hippocampal neurons were treated with E 2 (10 ng͞ml) or vehicle control for 48 h before loading in the dark with Fura2-AM (2 M) or Fura4F-AM (2 M) in Hanks' balanced salt solution (45 min; 37°C). For the Fura2 studies, [Ca 2ϩ ] i was determined by comparing the 340͞380 ratio to a standard curve as described (13) ] i levels, oligomycin (5 g͞ml) was perfused, and 3 min later the cells were exposed to the protonophore FCCP (2.5 M) and assessed for change in Fura4F ratio.
To determine that equal loading of dye occurred in the absence or presence of E 2 , the procedure of Dineley et al. (16) was used. Neurons loaded with Fura2-AM or Fura4F-AM as above were lysed in low ionic strength buffer (120 mM KCl͞10 mM Hepes͞0.2 mM EGTA, pH 7.2), centrifuged (10 min at 10,000 ϫ g), and dye concentration was determined in the supernatant under Ca Glutamate Toxicity. Cultures were exposed to E 2 (10 ng͞ml) or vehicle control 48 h before glutamate exposure for 5 min at 37°C in buffer containing 2 mM KCl, 1 mM MgSO 4 , 2.5 mM CaCl 2 , 1 mM NaHPO 4 , 4.2 mM NaHCO 3 , 12.5 mM Hepes, 10 mM glucose, 0.1 M NaCl, and 200 M L-glutamic acid. Cultures were washed and returned to fresh Neurobasal medium. Neuronal cell counts were performed before and 24 h after exposure to excitotoxic glutamate by using gridded coverslips as described (14) . One hundred neurons per coverslip were selected for study, and there were three coverslips per condition per experiment for a total of 300 neurons per condition per experiment. Data are presented as mean Ϯ SEM for at least three independent experiments. Neuronal injury was assessed 24 h after excitotoxic glutamate exposure by quantitative measurement of lactate dehydrogenase (LDH) release with a Cytotoxicity Detection kit (Roche Molecular Biochemicals). Data were normalized against the amount of LDH activity released from control cultures receiving glutamate (100%) and were corrected for baseline LDH release from control cells exposed only to buffer. Data are presented as mean Ϯ SEM for at least three independent experiments.
Bcl-2 Expression. E 2 (10 ng͞ml) was added to cultures for 48 h, and whole-cell lysates were obtained with lysis buffer (0.005% SDS͞ 0.1% Igepal͞0.2 mM sodium orthovanadate͞0.2 mM PMSF in PBS). Protein concentration was determined by bicinchoninic acid protein assay (Sigma). Protein was separated on 10% SDS͞PAGE, electrotransferred to poly(vinylidene difluoride) membrane (Millipore), and probed with anti-Bcl-2 antibody (1:250; Zymed) followed by horseradish peroxidase-conjugated horse anti-mouse IgG (1:10,000; Vector Laboratories). Bands were visualized by 3,3Ј,5,5Ј-Tetramethylbenzidine Peroxidase Substrate kit (Vector Laboratories). Relative levels of Bcl-2 were quantitated by optical density analysis with UN-SCAN-IT software (Silk Scientific, Orem, UT). To avoid interassay variations, values were normalized to the control value in each experiment. Data are presented as the mean Ϯ SEM for at least three independent experiments.
Statistics. Statistically significant differences between groups were determined by an ANOVA followed by a Newman-Keuls post hoc analysis. with a mean change in [Ca 2ϩ ] i of 223.0 Ϯ 69.8 nM (P Ͻ 0.05; n ϭ 4 experiments; Fig. 1B ).
Results

17␤-Estradiol
In the presence of an excitotoxic concentration of glutamate (200 M), a rapid increase in [Ca 2ϩ ] i that was larger than that induced by 25 M glutamate occurred ( Fig. 1 C and D) . Paradoxically, in contrast to the potentiation of the 25-M glutamate response, in the presence of 200 M glutamate E 2 significantly attenuated the [Ca 2ϩ ] i rise induced by excitotoxic glutamate (Fig. 1C) . The mean change in [Ca 2ϩ ] i obtained on stimulation with 200 M glutamate was 427.9 Ϯ 49.6 nM (n ϭ 4; Fig. 1D ). In hippocampal neurons pretreated with E 2 , the mean change in [Ca 2ϩ ] i stimulated by 200 M glutamate was 288.4 Ϯ 31.5 nM, representing an Ϸ33% decrease in ⌬[Ca 2ϩ ] i (P Ͻ 0.05; n ϭ 4; Fig. 1D ) . Although the high affinity of Fura2 for Ca 2ϩ provides an excellent strategy for determining changes in Ca 2ϩ transients, the same high affinity is a hindrance when determining maximal elevations of Ca 2ϩ under conditions of exposure to excitotoxic concentrations of glutamate (19, 20) . To address this potential problem, we used Fura4F (K d Ϸ770 nM), a Ca 2ϩ indicator with an affinity Ϸ3.4-fold lower than that of Fura2 (K d Ϸ224 nM), to confirm that the attenuation of the excitotoxic glutamateinduced Ca 2ϩ rise was not due to a saturation of the high-affinity Fura2. In both control and E 2 -treated neurons, glutamate induced a rapid increase in the Fura4F fluorescence ratio (Fig. 3) . Consistent with the results obtained with Fura2, steady-state [Ca 2ϩ ] i was significantly lower in E 2 -treated neurons compared with control neurons. The mean change from baseline to steadystate Fura4F fluorescence ratio obtained on stimulation with 200 M glutamate was 0.930 Ϯ 0.12 (n ϭ 3; Fig. 3 ). In hippocampal neurons pretreated with E 2 , the mean change in the Fura4F fluorescence ratio stimulated by 200 M glutamate was 0.781 Ϯ 0.18, representing an Ϸ17% decrease (P Ͻ 0.05; n ϭ 3; Fig. 3) . Use of the low-affinity dye revealed an initial peak in [Ca 2ϩ ] i that was followed by a rapid decline to steady-state levels. This initial peak was larger in E 2 -treated neurons than in control neurons (mean change in Fura4F fluorescence ratios of 1.375 Ϯ 0.09 and 1.192 Ϯ 0.06, respectively).
To determine whether the site of E 2 action was at the point of Ca 2ϩ influx, we investigated whether E 2 regulated glutamateinduced uptake of Ca 2ϩ . Because Fura2 and -4F measures bulk cytoplasmic-free Ca 2ϩ and not total Ca ] i (Fig. 4A ) with a mean change in Fura4F fluorescence ratio of 1.294 Ϯ 0.04 (n ϭ 3; Fig. 4B ). In the presence of rotenone and oligomycin, the glutamate-stimulated increase in [Ca 2ϩ ] i was significantly enhanced by pretreatment with E 2 (Fig. 4A ) with a mean change in Fura4F fluorescence ratio of 1.543 Ϯ 0.05 (P Ͻ 0.05; n ϭ 3; Fig. 4B ). Similar results were obtained with Fura2 (data not shown).
Although rotenone inhibits respiratory chain complex I, mitochondrial function can be supported by complex II by using succinate as a substrate. Further confounding the analysis, previous reports indicate that oligomycin can interfere with glutamate-stimulated Ca 2ϩ influxes (22, 23) . Thus these mitochondrial inhibitors could exert effects beyond inhibiting mitochondrial Ca 2ϩ uptake. To address these pharmacological shortcomings, we used the selective inhibitor of complex III, antimycin, which has been shown to increase the amplitude of the excitotoxic glutamate-induced rise in [Ca 2ϩ ] i (24) . It has been shown that primary hippocampal neurons can maintain their ATP levels in the presence of antimycin for up to 2 h (24), obviating the need for addition of oligomycin, which may interfere with glutamate-stimulated Ca 2ϩ influxes (22, 23) . In the presence of antimycin (2.5 M), glutamate induced a rapid increase in [Ca 2ϩ ] i that was consistent with the expected value ( Fig. 4C ) with a mean change in Fura4F ratio of 1.448 Ϯ 0.06 (n ϭ 3; Fig. 4D ). In the presence of antimycin, glutamatestimulated increase in [Ca 2ϩ ] i was significantly enhanced by pretreatment with E 2 (Fig. 4C ) with a mean change in Fura4F fluorescence ratio of 1.741 Ϯ 0.09 (P Ͻ 0.05; n ϭ 3; Fig. 4D ). Similar results were obtained when Fura2 was used instead of Fura4F (data not shown).
Both the oligomycin plus rotenone and antimycin pretreatments abolished the decline in [Ca 2ϩ ] i , resulting in a sustained Ca 2ϩ level after glutamate stimulation (Fig. 4) , indicating that the decline is due to mitochondrial sequestration of intracellular Ca 2ϩ . Additionally, the [Ca 2ϩ ] i levels reached in the presence of the mitochondrial inhibitors is higher than the peak rise observed in their absence. In the absence of mitochondrial inhibitors, the peak rise in Fura4F fluorescence ratio was 1.192 Ϯ 0.08 over baseline (Fig. 2) . In presence of oligomycin plus rotenone or antimycin, the rise in Fura4F fluorescence ratio was 1.294 Ϯ 0.04 and 1.448 Ϯ 0.06, respectively (Fig. 4) . This rise indicates that mitochondrial sequestration of Ca ] m (24, 27) . To offset artifacts secondary to depletion of ATP by FCCP, the ATP synthase inhibitor oligomycin was applied before the addition of FCCP. In the presence of oligomycin, glycolysis can maintain the ATP͞ADP ratios, which are not affected by the addition of FCCP (27, 28) . The addition of FCCP resulted in a greater magnitude of mitochondrial Ca 2ϩ release in E 2 -treated neurons than in control neurons (Fig. 3E) . Similar results were obtained when Fura2 was used instead of Fura4F (data not shown). Calculation of Ca 2ϩ release (defined as the difference between the final fluorescence after FCCP addition and the steady-state f luorescence that occurred during glutamate exposure) indicated a change in Fura4F fluorescence ratio of 1.996 Ϯ 0.13 for E 2 -treated cells and 1.284 Ϯ 0.19 for control cells (P Ͻ 0.01; n ϭ 3; Fig. 4F ). The Fura4F ratio change was Ϸ1.5 times higher in the E 2 -treated neurons (E 2 ͞control ϭ 1.5 Ϯ 0.4; n ϭ 3).
Estrogen Protects Against Excitotoxic Cell Death and Increases Bcl-2
Expression. Ca 2ϩ uptake by mitochondria is thought to contribute to toxicity (7, 29) . Thus, the increased [Ca 2ϩ ] m loads induced by E 2 treatment would be expected to lead to increased neuronal death, which is antithetical to E 2 protection against glutamate excitotoxicity (1, 3) . Experiments were performed to determine the protective effect of E 2 against glutamate neurotoxicity under the conditions used previously. A 5-min treatment of 200 M glutamate caused significant cell death as determined by survival cell counts (Fig. 5A ) and LDH release (Fig. 5B) . A 48-h pretreatment with E 2 significantly reduced the amount of neuronal death (Fig. 5A ) and the amount of LDH released (Fig. 5B) .
Mitochondria derived from Bcl-2-expressing cells have a higher capacity for Ca 2ϩ uptake and a greater resistance to Ca 2ϩ -induced respiratory injury than mitochondria from cells that do not express Bcl-2 (15, 30) . Furthermore, studies have reported that E 2 increases the expression of Bcl-2 in neuronal cell lines and in rat brain (31) (32) (33) (34) . To determine whether E 2 regulated Bcl-2 expression in parallel to both the sequestration of [Ca 2ϩ ] m and neuron survival, we determined Bcl-2 expression by Western blot analysis in primary hippocampal neurons. E 2 treatment (10 ng͞ml; 48 h) resulted in an Ϸ2-fold increase in Bcl-2 expression that was significantly greater than control (Fig. 5C ).
Discussion
In this study, we sought to resolve the paradox of dual regulation of [Ca 2ϩ ] i by E 2 in hippocampal neurons after nontoxic and excitotoxic glutamate exposure. Contrary to the potentiation of ] i rise in the response to excitotoxic glutamate. Our prior work has shown that the opposing actions are not unique to E 2 but are induced by other clinically relevant estrogen replacement therapies, such as conjugated equine estrogens used in the Women's Health Initiative (13). That we were able to demonstrate the attenuation of the Ca 2ϩ rise induced by glutamate by using the lower affinity dye, Fura4F, indicated that the results were not due to saturation artifacts sometimes observed with the high-affinity dye Fura2 for determining [Ca 2ϩ ] in response to high concentrations of glutamate (19, 20) . Although the attenuation of the steady-state glutamateinduced [Ca 2ϩ ] i was detected with both Fura2 and Fura4F, we were unable to observe the initial peak in [Ca 2ϩ ] i by using Fura2, possibly due to the differing kinetics of the two dyes. The use of both Ca 2ϩ indicators provided optimal analysis with Fura2, providing a better indication of the magnitude of the E 2 effect, whereas Fura4F provided greater detail of the dynamics of Ca 2ϩ signaling.
The initial [Ca 2ϩ ] i peak that was observed with Fura4F was higher in the E 2 -treated neurons than in the control neurons, an effect consistent with the E 2 -mediated potentiation of the 45 Ca 2ϩ uptake induced by both 25 and 200 M glutamate (Fig. 2) . These results are consistent with the reported enhancement of Nmethyl-D-aspartate (NMDA)-mediated excitatory postsynaptic potentials by E 2 (17 sequestration by mitochondria. The use of mitochondrial inhibitors, (i) a combination of rotenone (to inhibit the respiratory chain at complex I) and oligomycin (to inhibit mitochondrial ATP synthase) or (ii) antimycin (to inhibit the respiratory chain at complex III) completely depolarizes in situ mitochondria, effectively blocking mitochondrial Ca 2ϩ accumulation (22, 24) . By using this model as a tool, E 2 -induced attenuation of the [Ca 2ϩ ] i rise was revealed to depend on mitochondrial sequestration of Ca 2ϩ (Fig. 4) . These data were validated by the opposite experiment in which blockade of mitochondrial Ca 2ϩ sequestration resulted in a significant increase in [Ca 2ϩ ] i after exposure to excitotoxic glutamate in E 2 -treated neurons. This result is consistent with the E 2 potentiation of Ca sequestration. Our results obtained in neurons may be applicable to other estrogen-responsive mitochondrial tissues. For example, liver mitochondria isolated from rats treated with E 2 show enhanced respiratory substratedependent binding of Ca 2ϩ than mitochondria from control rats (35, 36) .
Mitochondrial Ca 2ϩ sequestration depends on uptake through the uniporter and efflux due to exchange for Na ϩ via a mitochondrial Na ϩ ͞Ca 2ϩ transporter (37) . Thus mitochondria behave as buffers of extramitochondrial Ca 2ϩ , accumulating the cation whenever its concentration rises above the threshold at which uptake and efflux balance and releasing Ca 2ϩ below this level (9) . The data in the present study support a model in which E 2 potentiates the Ca Fig. 1 A and B) and attenuation of the [Ca 2ϩ ] i rise induced by 200 M glutamate (Figs. 1 C and D and 3 A and B) .
Further supporting a model of E 2 -induced mitochondrial sequestration of Ca 2ϩ , we demonstrated that E 2 treatment resulted in increased mitochondrial Ca 2ϩ sequestration in intact neurons after exposure to excitotoxic glutamate. Maintenance of [Ca 2ϩ ] m levels depends on the proton gradient across the inner membrane, allowing one to use the protonophore FCCP as a tool to dissipate the electrochemical gradient resulting in release of mitochondrial Ca 2ϩ (24, 27, 38) . The release of [Ca 2ϩ ] m is manifested as an increase in [Ca 2ϩ ] i , which can be detected by calcium indicator dyes (38) . Collapse of the mitochondrial membrane potential by FCCP may also reverse ATP synthesis, leading to rapid hydrolysis of cytoplasmic ATP (27) , preventing Na ϩ and Ca 2ϩ extrusion from the cell (39) . To prevent artifactual increases in [Ca 2ϩ ] i due to depletion of ATP by FCCP, the mitochondrial ATP synthase inhibitor oligomycin was added before FCCP exposure. In the presence of oligomycin, neurons can maintain ATP͞ADP ratios by glycolysis, and there is no further drop in ATP levels with FCCP administration (27, 28) . In the present study, we showed that administration of FCCP, in the presence of oligomycin, after an excitotoxic glutamate stimulus (200 M) resulted in a significantly greater release of mitochondrial Ca 2ϩ stores from E 2 -treated cells than from control cells (Fig. 5 E and F) . These data indicate that E 2 -induced increase in mitochondrial Ca 2ϩ sequestration is coupled with an increased [Ca 2ϩ ] m load. Although the E 2 -induced reduction in cytosolic Ca 2ϩ contributes to the neuroprotection, excessive Ca 2ϩ sequestration into mitochondria can lead to mitochondrial dysfunction and subsequent cell death (7, 21, 25, 29 ] m load in response to excitotoxic glutamate to result in increased neuronal death, not increased survival. However, E 2 consistently protects against glutamate-induced neurotoxicity. We showed that under the conditions used previously for Ca 2ϩ imaging, E 2 protects against glutamate-induced neurotoxicity (Fig. 5) , which is consistent with the reported neuroprotective effect of E 2 (1) (2) (3) (4) . If E 2 increases mitochondrial Ca 2ϩ sequestration and protects against glutamate excitotoxicity, then it follows that mitochondrial Ca 2ϩ load tolerability has been altered. Preservation of mitochondrial function by E 2 is in agreement with reports that show E 2 pretreatment maintains ATP production and mitochondrial membrane potential in the face of oxidative stress and mutant presenilin-1 (40, 41) . Thus, rather than mediating neuroprotection via reduced cytosolic Ca 2ϩ levels, the more prominent mechanism of E 2 -induced neuroprotection against glutamate excitotoxicity is via alteration of mitochondrial function, including increased Ca 2ϩ load tolerability.
There is an apparent limit to the amount of Ca 2ϩ that mitochondria can accumulate, illustrated by a decrease in the ratio of Ca 2ϩ released by FCCP to that released by glutamate on higher levels of glutamate exposure (38) . One proposed mechanism to increase mitochondrial Ca 2ϩ load tolerability is through increased expression of the antiapoptotic protein Bcl-2. Bcl-2 is localized to the mitochondrial membrane and its expression significantly enhances the capacity for mitochondrial Ca 2ϩ sequestration (15) . In addition to increasing the magnitude of Ca 2ϩ sequestered by mitochondria, Bcl-2 enhances the tolerability of mitochondria for increased levels of [Ca 2ϩ ] i that would otherwise result in dissipation of ⌬⌿ m and cell death (30) . Bcl-2 has been identified as an estrogen-responsive gene in reproductive tissues (42) , as well as in neurons (31) (32) (33) (34) . In the current study, we confirmed that E 2 induces increased Bcl-2 expression in primary hippocampal neurons. Thus, we hypothesize that by increasing [Ca 2ϩ ] m uptake capacity, and resultant resistance to Ca 2ϩ -induced respiratory inhibition conferred by Bcl-2, E 2 limits the loss of viability initiated by excitotoxic glutamate.
Collectively, these data indicate that E 2 treatment of primary hippocampal neurons results in increased mitochondrial sequestration of Ca 2ϩ in response to excitotoxic glutamate, which leads to an attenuation of the rise in bulk-free [Ca 2ϩ ] i . The E 2 -induced attenuation is correlated with an increase in Bcl-2 expression, which could provide a mechanism by which neurons are protected against deleterious effects of the increased [Ca 2ϩ ] m induced by E 2 . Our work is aimed at determining the mechanisms whereby E 2 promotes mitochondrial sequestration of Ca 2ϩ and mitochondrial viability in the face of increased Ca 2ϩ load.
